Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/155833
Registo completo
Campo DCValorIdioma
dc.creatorNeto, R, Frazão, J
dc.date.accessioned2023-12-15T12:31:22Z-
dc.date.available2023-12-15T12:31:22Z-
dc.date.issued2021
dc.identifier.issn2048-8505
dc.identifier.urihttps://hdl.handle.net/10216/155833-
dc.description.abstractBackground: Disordered bone and mineral metabolism are a common complication of chronic kidney disease (CKD). Phosphate binders are often prescribed in advanced CKD, when hyperphosphataemia develops. Little is known about the role of these drugs in earlier stages, when serum phosphorus levels are kept in the normal range by increased urinary excretion. Methods: A retrospective, controlled observational study was conducted on a cohort of 78 pre-dialysis patients. Subjects had CKD Stage 3 or 4, normal serum phosphorus levels and increased urinary fractional excretion of phosphate. Thirty-eight patients receiving calcium carbonate for 24 months were compared with 40 patients under no phosphate binders, regarding mineral metabolism parameters and vascular calcification scores. Results: Calcium carbonate decreased mean urinary fractional excretion of phosphate and median 24-h urine phosphorus, whereas no significant change was seen in the control group. Mean serum phosphorus and median serum intact parathyroid hormone (iPTH) remained stable in treated patients but increased in the control group. Vascular calcification, assessed by Kauppila and Adragão scores, worsened under calcium carbonate with no significant change in the control group. Conclusions: Calcium carbonate reduced urinary phosphate excretion and prevented the rise in phosphorus and iPTH serum levels in a cohort of normophosphataemic pre-dialysis patients. However, treatment was associated with increased vascular calcification, suggesting that calcium-based phosphate binders are not a safe option for CKD patients.
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.ispartofClinical Kidney Journal, vol.14(2), p. 550-555
dc.rightsopenAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectCalcium carbonate
dc.subjectPhosphate binders
dc.subjectPre-dialysis patients
dc.subjectUrinary fractional excretion of phosphate
dc.subjectVascular calcification
dc.titleEfficacy and safety of calcium carbonate in normophosphataemic patients with chronic kidney disease Stages 3 and 4
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.1093/ckj/sfz181
dc.relation.publisherversionhttps://academic.oup.com/ckj/article/14/2/550/5684868?login=true
Aparece nas coleções:I3S - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
10.1093-ckj-sfz181.pdf510.49 kBAdobe PDFThumbnail
Ver/Abrir


Este registo está protegido por Licença Creative Commons Creative Commons